COVID News

The two potential COVID-19 vaccines that Moderna and the team of Pfizer and BioNTech have developed each will require two doses. But that's not unusual, say infectious disease specialists. Rather, it's how a vaccine becomes most effective.

Several reviews have been published suggesting the use of melatonin for the treatment of COVID-19. But it is critical to stress that more robust clinical and experimental studies and data are necessary before a well-founded, evidence-based decision can be made.

If moms are infected with COVID-19, it should still be okay to breastfeed, as long as necessary sanitary precautions such as mask-wearing and hand-washing are in place. And now, a new study finds that breastmilk could potentially be beneficial against COVID in babies. Here's how breastmilk protects.

Pfizer, the first company to announce their findings last week, announced today that they would be seeking emergency authorization for use from the FDA to begin production of the vaccine. The projected date for approval hasn't been released though, so don't get too excited just yet.

With the recent approval of Lucira Health's All-In-One COVID-19 self-test kit, you will be able to significantly lower your risk of exposing others by testing in the privacy of your home. Here's what you should know about the new at-home COVID-19 test, from its accuracy to speed.

A potential COVID-19 vaccine from drug manufacturers Pfizer and BioNTech needs to be distributed in extreme cold, causing an uptick in sales of dry ice and medical-grade freezers. This is why Pfizer's potential COVID-19 vaccine is boosting dry ice sales currently.

The Massachusetts-based biotechnology company Moderna announced Monday that its potential COVID-19 vaccine has proven 94.5 percent effective during a trial, making it the second possible coronavirus vaccine to have a high success rate. How does it compare to Pfizer's vaccine?

If you're struggling to stay vigilant and aware of what's happening with the COVID-19 pandemic, you're not alone: COVID fatigue is a real thing, and it's dangerous.

For so many of us, a COVID-19 vaccine holds the hope of returning to a semblance of normal life. So, news from drug-maker Moderna is being cheered from coast to coast as they announced their vaccine has shown to be 94.5 percent effective in early testing.

Genetics and gender may determine both your risk of contracting COVID-19 and how sick you'll become, according to two new studies researching genes and the body's immune system.

As the biotech world moves closer to getting a COVID-19 vaccine approved, details about the specifics of such treatment are coming into focus. One question is — how much the vaccine is going to cost? And do Americans need to budget for it, or will health insurance cover it?

Pzifer, in collaboration with German biotechnology company BioNTech, has released new information about the development of its coronavirus vaccine. While these results are promising, more work needs to be done. If things are good to go, though, when could it be available?

For months, the world has been eagerly awaiting news of advancements in the development of a vaccine for COVID-19. One vaccine trial has finally announced some promising results. What has to happen before this COVID-19 vaccine is approved?

Early on in the pandemic, doctors noticed a symptom among patients with coronavirus: a loss of taste. Until now, they've been unsure why the virus causes this, but new research indicates that cells in the mouth are a key player in both the loss of taste and the growth and spread of the illness.

If scientists are successful, the phrase, 'There's an app for that!' soon could apply to being able to detect the coronavirus, even in people who show no symptoms.

A new study of grocery workers in Boston, Massachusetts, suggests that grocery store employees are at greater risk of contracting COVID-19. Also, since a majority of those in the study showed no symptoms, these workers could be a significant transmission source of the coronavirus, researchers said.

Two studies released this month show that men worldwide are less likely to perceive COVID-19 as a serious health problem and to follow preventative behaviors — something that puts their lives more in jeopardy.

The flu vaccine won't protect you against the coronavirus — but it won't make you more vulnerable to catching COVID-19, either, says the CDC.

It's been eight months since life changed into a socially-distanced, mask-wearing reality. Yet even now, scientists are still learning new things about the coronavirus and how it impacts the human body. A new complication showing up in adults has doctors concerned.

Residents in rural America may be more at risk for the coronavirus than previously thought because of certain risk factors that densely populated cities don't have, researchers say.

How well you fare from a coronavirus infection might seem a little like Russian roulette — on one hand, you have the asymptomatic carriers, and on the other, you have the more than 218,000 deaths in the United States alone. Once you've gone through it once, though, can you get it again?

There are reports that there is a possible outcome of a COVID diagnosis that we all need to be aware of. It's called 'long-haul COVID, which refers to the fact that some sufferers may take many months to recover from their virus symptoms.

Ready for some good news about the pandemic? Because as it turns out, there actually is such a thing. A study published by the American Academy of Pediatrics found that there was not a heightened risk of COVID-19 infection among childcare workers compared to adults in other lines of work.

One of the factors that medical science is taking into account for coronavirus infection is blood type, and they may have discovered a connection, or at least a correlation, between your blood type and your likelihood of becoming infected with COVID.

The actual number of global COVID-19 cases and fatalities may be far higher than thought, says the World Health Organization (WHO), which said Monday that the virus may have infected about 10 percent of the world's population, or roughly 760 million people.

With the end of summer and the gradual loss of daylight, you may be tempted to stock up on vitamin D. Known as the "sunshine vitamin" because our bodies produce it in response to sunlight, ensuring you have adequate levels of this vitamin could also be the key to staving off COVID-19 this fall.

While it seems that no one group of people is entirely safe from the COVID-19 virus, there are certain groups who are more at risk, not just of infection, but of complications resulting from the illness. One such group is women who are, or may become, pregnant during the pandemic.